Literature DB >> 31213376

Surgical aortic valve replacement with new-generation bioprostheses: Sutureless versus rapid-deployment.

Augusto D'Onofrio1, Stefano Salizzoni2, Claudia Filippini3, Chiara Tessari4, Lorenzo Bagozzi4, Antonio Messina5, Giovanni Troise5, Margerita Dalla Tomba5, Manfredo Rambaldini6, Magnus Dalén7, Francesco Alamanni8, Massimo Massetti9, Carmelo Mignosa10, Claudio Russo11, Loris Salvador12, Roberto Di Bartolomeo13, Daniele Maselli14, Ruggero De Paulis15, Ottavio Alfieri16, Carlo Maria De Filippo17, Michele Portoghese18, Uberto Bortolotti19, Mauro Rinaldi2, Gino Gerosa4.   

Abstract

OBJECTIVES: The aim of this retrospective multicenter study was to compare early clinical and hemodynamic outcomes of Perceval-S sutureless (Livanova, London, United Kingdom) and Intuity rapid-deployment (Edwards Lifesciences, Irvine, Calif) bioprostheses.
METHODS: Data from patients who underwent isolated or combined aortic valve replacement with Perceval-S and with Intuity bioprostheses at 18 cardiac surgical institutions were analyzed. Propensity matching was performed to identify similar patient cohorts.
RESULTS: We included 911 patients from March 2011 until May 2017. Perceval-S and Intuity valves were implanted in 349 (38.3%) and in 562 (61.7%) patients, respectively. Propensity score identified 117 matched pairs. In the matched cohort, device success was 99.1% and 100% in Perceval-S and Intuity group, respectively (P = 1.000). Thirty-day Valve Academic Research Consortium mortality occurred in 2 (1.7%) and 4 (3.4%) patients in the Perceval-S and in Intuity group, respectively (P = .6834). The rate of postoperative new permanent pacemaker implantation was 6% (7 patients) and 6.8% (8 patients) in the Perceval-S and in Intuity group, respectively (P = .7896). Perceval-S valve implantation requires significantly shorter aortic crossclamp and cardiopulmonary bypass times than Intuity valve implantation (aortic crossclamp time for isolated, 52 ± 14 minutes vs 62 ± 24 minutes; P < .0001). Peak transaortic gradients were 22.4 ± 8.1 mm Hg and 19.6 ± 6.7 mm Hg (P = .0144), whereas mean gradients were 11.8 ± 4.7 mm Hg and 10.5 ± 3.9 mm Hg (P = .0388) in the Perceval-S and Intuity groups, respectively.
CONCLUSIONS: Sutureless Perceval-S and rapid-deployment Intuity bioprostheses provide good and similar early clinical and hemodynamic outcomes. Perceval-S valve implantation requires shorter crossclamp and cardiopulmonary bypass times, whereas Intuity valve implantation provides lower transaortic peak and mean gradients.
Copyright © 2019 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  aortic valve; rapid deployment aortic bioprosthesis; replacement; sutureless aortic bioprosthesis

Year:  2019        PMID: 31213376     DOI: 10.1016/j.jtcvs.2019.02.135

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  11 in total

1.  Long-term outcomes of sutureless and rapid-deployment aortic valve replacement: a systematic review and meta-analysis.

Authors:  Michael L Williams; Campbell D Flynn; Andrew A Mamo; David H Tian; Utz Kappert; Manuel Wilbring; Thierry Folliguet; Antonio Fiore; Antonio Miceli; Augusto D'Onofrio; Giorgia Cibin; Gino Gerosa; Mattia Glauber; Theodor Fischlein; Francesco Pollari
Journal:  Ann Cardiothorac Surg       Date:  2020-07

2.  Sutureless valve and rapid deployment valves: a systematic review and meta-analysis of comparative studies.

Authors:  Campbell D Flynn; Michael L Williams; Adam Chakos; Lucy Hirst; Benjamin Muston; David H Tian
Journal:  Ann Cardiothorac Surg       Date:  2020-09

Review 3.  Oversampling and replacement strategies in propensity score matching: a critical review focused on small sample size in clinical settings.

Authors:  Daniele Bottigliengo; Ileana Baldi; Corrado Lanera; Giulia Lorenzoni; Jonida Bejko; Tomaso Bottio; Vincenzo Tarzia; Massimiliano Carrozzini; Gino Gerosa; Paola Berchialla; Dario Gregori
Journal:  BMC Med Res Methodol       Date:  2021-11-22       Impact factor: 4.615

4.  Recent improvement in operative techniques lead to lower pacemaker rate after Perceval implant.

Authors:  Olivier Fabre; Mihai Radutoiu; Ionut Carjaliu; Olivier Rebet; Laurence Gautier; Ilir Hysi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-07-09

5.  The Caged-Ball Prosthesis 60 Years Later: A Historical Review of a Cardiac Surgery Milestone.

Authors:  Andrea De Martino; Aldo D Milano; Mila Della Barbera; Gaetano Thiene; Uberto Bortolotti
Journal:  Tex Heart Inst J       Date:  2022-03-01

6.  Mid-term assessment of structural valve deterioration of perceval S sutureless prosthesis using the last European consensus definition.

Authors:  José Manuel Martínez-Comendador; Francisco Estevez-Cid; Miguel González Barbeito; Carlos Velasco García De Sierra; Alberto Bouzas Mosquera; Cayetana Barbeito; José Cuenca Castillo; José Herrera-Noreña
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-04-19

7.  A pooled analysis of pacemaker implantation after Perceval sutureless aortic valve replacement.

Authors:  Marco Moscarelli; Giuseppe Santarpino; Thanos Athanasiou; Pasquale Mastroroberto; Khalil Fattouch; Giuseppe Nasso; Giuseppe Speziale
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-10-04

8.  Direct comparison of rapid deployment versus sutureless aortic valve replacement: a meta-analysis.

Authors:  Suk Ho Sohn; Yoonjin Kang; Ji Seong Kim; Jae Woong Choi; Myoung-Jin Jang; Ho Young Hwang
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

Review 9.  Recent advances in aortic valve replacement.

Authors:  Cristiano Spadaccio; Khalid Alkhamees; Nawwar Al-Attar
Journal:  F1000Res       Date:  2019-07-22

Review 10.  Use of Sutureless and Rapid Deployment Prostheses in Challenging Reoperations.

Authors:  Igor Vendramin; Andrea Lechiancole; Daniela Piani; Gaetano Nucifora; Giovanni Benedetti; Sandro Sponga; Daniele Muser; Uberto Bortolotti; Ugolino Livi
Journal:  J Cardiovasc Dev Dis       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.